首页 > 最新文献

Plastic surgery最新文献

英文 中文
Commentary on: Breast Reconstruction Perceptions and Access in First Nations Women Are Influenced by Colonization. 特邀讨论:第一民族妇女的乳房重建观念和途径受到殖民的影响
IF 0.7 4区 医学 Q4 SURGERY Pub Date : 2024-11-01 Epub Date: 2023-05-17 DOI: 10.1177/22925503231172794
Oluwatobi Olaiya, Lucas Gallo, Mark H McRae
{"title":"Commentary on: Breast Reconstruction Perceptions and Access in First Nations Women Are Influenced by Colonization.","authors":"Oluwatobi Olaiya, Lucas Gallo, Mark H McRae","doi":"10.1177/22925503231172794","DOIUrl":"10.1177/22925503231172794","url":null,"abstract":"","PeriodicalId":20206,"journal":{"name":"Plastic surgery","volume":null,"pages":null},"PeriodicalIF":0.7,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11490957/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"43689044","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Temporal Sequencing of Multimodal Treatment in Immediate Breast Reconstruction and Implications for Wait Times: A Regional Canadian Cross-Sectional Study. 即刻乳房重建中多模式治疗的时间排序及其对等待时间的影响:一项加拿大地区横断面研究
IF 0.7 4区 医学 Q4 SURGERY Pub Date : 2024-11-01 Epub Date: 2023-02-07 DOI: 10.1177/22925503231152261
Karanvir S Raman, Maya Morton Ninomiya, Esta S Bovill, Christopher Doherty, Sheina A Macadam, Nancy Van Laeken, Kathryn V Isaac

Introduction: Treatment of breast cancer requires a multimodal approach with numerous independent specialists. Immediate breast reconstruction (IBR) adds another layer of coordination to comprehensive breast cancer care. To optimize health outcomes for patients seeking IBR, it is essential to efficiently coordinate the temporal sequence of care modalities inclusive of reconstruction. Methods: In this cross-sectional study, patients undergoing IBR following complete or partial mastectomy at one health centre from 2015 to 2021 were included. Patients were categorized into two main groups defined by the first treatment modality received, namely surgery first and Neoadjuvant Chemotherapy. Primary outcome measures were wait times for diagnostic investigations, initiation of treatment, and transitions between therapeutic modalities. Results: Of 195 patients, 158 underwent surgery first, and 37 underwent neoadjuvant chemotherapy. Median wait time from first consultation to first treatment initiated in the neoadjuvant cohort was shorter by 11.5 days as compared to the Surgery First cohort (21.5 +/- 19 vs 33.0 +/- 28 days; P = 0.001). Twenty-three (82%) of the surgery first and 11 (38%) of the neoadjuvant cohort patients waited longer than 8 weeks for initiation of radiotherapy (P = 0.001). Following surgical intervention, the majority of patients failed to meet target benchmarks for transition to chemotherapy (n = 25, 53%) and transition to radiotherapy (n = 26, 93%; P < 0.001). Conclusion: Patients undergoing IBR may incur delays in the setting of upfront surgery and in transitioning to adjuvant therapies. In the setting of breast reconstruction, further efforts are required to achieve target wait-times in multimodal breast cancer care.

简介:乳腺癌的治疗需要多模式的方法与众多独立的专家。即时乳房重建(IBR)为全面的乳腺癌护理增加了另一层协调。为了优化寻求IBR的患者的健康结果,必须有效地协调包括重建在内的护理模式的时间顺序。方法:在这项横断面研究中,纳入了2015年至2021年在一家健康中心接受乳房完全或部分切除术后IBR的患者。根据首次接受的治疗方式将患者分为两组,即先手术和新辅助化疗。主要结果测量是诊断调查的等待时间,开始治疗,以及治疗方式之间的转换。结果:195例患者中,先行手术158例,新辅助化疗37例。新辅助队列从首次问诊到首次开始治疗的中位等待时间比首次手术队列短11.5天(21.5 +/ - 19 vs 33.0 +/ - 28天;p = 0.001)。23例(82%)的首次手术患者和11例(38%)的新辅助队列患者等待超过8周才开始放疗(P = 0.001)。手术干预后,大多数患者未能达到过渡到化疗(n = 25, 53%)和过渡到放疗(n = 26, 93%)的目标基准;p < 0.001)。结论:接受IBR的患者可能会延迟前期手术的设置和过渡到辅助治疗。在乳房重建的情况下,需要进一步努力实现多模式乳腺癌护理的目标等待时间。
{"title":"Temporal Sequencing of Multimodal Treatment in Immediate Breast Reconstruction and Implications for Wait Times: A Regional Canadian Cross-Sectional Study.","authors":"Karanvir S Raman, Maya Morton Ninomiya, Esta S Bovill, Christopher Doherty, Sheina A Macadam, Nancy Van Laeken, Kathryn V Isaac","doi":"10.1177/22925503231152261","DOIUrl":"10.1177/22925503231152261","url":null,"abstract":"<p><p><b>Introduction:</b> Treatment of breast cancer requires a multimodal approach with numerous independent specialists. Immediate breast reconstruction (IBR) adds another layer of coordination to comprehensive breast cancer care. To optimize health outcomes for patients seeking IBR, it is essential to efficiently coordinate the temporal sequence of care modalities inclusive of reconstruction. <b>Methods:</b> In this cross-sectional study, patients undergoing IBR following complete or partial mastectomy at one health centre from 2015 to 2021 were included. Patients were categorized into two main groups defined by the first treatment modality received, namely surgery first and Neoadjuvant Chemotherapy. Primary outcome measures were wait times for diagnostic investigations, initiation of treatment, and transitions between therapeutic modalities. <b>Results:</b> Of 195 patients, 158 underwent surgery first, and 37 underwent neoadjuvant chemotherapy. Median wait time from first consultation to first treatment initiated in the neoadjuvant cohort was shorter by 11.5 days as compared to the Surgery First cohort (21.5 +/- 19 vs 33.0 +/- 28 days; <i>P</i> = 0.001). Twenty-three (82%) of the surgery first and 11 (38%) of the neoadjuvant cohort patients waited longer than 8 weeks for initiation of radiotherapy (<i>P</i> = 0.001). Following surgical intervention, the majority of patients failed to meet target benchmarks for transition to chemotherapy (<i>n</i> = 25, 53%) and transition to radiotherapy (<i>n</i> = 26, 93%; <i>P</i> < 0.001). <b>Conclusion:</b> Patients undergoing IBR may incur delays in the setting of upfront surgery and in transitioning to adjuvant therapies. In the setting of breast reconstruction, further efforts are required to achieve target wait-times in multimodal breast cancer care.</p>","PeriodicalId":20206,"journal":{"name":"Plastic surgery","volume":null,"pages":null},"PeriodicalIF":0.7,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11489937/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"43775878","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
An Approach to "Big Data". “大数据”之路
IF 0.7 4区 医学 Q4 SURGERY Pub Date : 2024-11-01 Epub Date: 2023-05-17 DOI: 10.1177/22925503231176010
Lucas Gallo, Oluwatobi Olaiya, Christopher J Coroneos
{"title":"An Approach to \"Big Data\".","authors":"Lucas Gallo, Oluwatobi Olaiya, Christopher J Coroneos","doi":"10.1177/22925503231176010","DOIUrl":"10.1177/22925503231176010","url":null,"abstract":"","PeriodicalId":20206,"journal":{"name":"Plastic surgery","volume":null,"pages":null},"PeriodicalIF":0.7,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11489901/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"44468229","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Local/Regional Anesthesia Versus General Anesthesia in Phalanx Fractures/Dislocations. Phalanx骨折/脱位的局部/区域麻醉与全身麻醉
IF 0.7 4区 医学 Q4 SURGERY Pub Date : 2024-11-01 Epub Date: 2023-06-20 DOI: 10.1177/22925503231180886
Matthew D Rich, Anna Rauzi, Thomas J Sorenson, Christopher Hillard, Ashish Y Mahajan

Background: Traditionally, surgical repair of phalanx fractures was performed under general anesthesia. However, the emergence of regional and local anesthesia, otherwise known as Wide-awake Local Anesthesia No Tourniquet, provides an alternative approach where general anesthesia is undesirable. The choice of anesthetic approach resides with clinicians, though it is important to factor in the evidence that regional/local provides not only an alternative anesthesia approach but also potentially avoids comorbidities associated with general anesthesia. This study hypothesizes that the use of local/regional anesthesia for phalanx fracture/dislocation has comparable outcomes to general anesthesia and provides for fewer adverse events. Methods: To answer the research purpose, the investigators designed and implemented a retrospective cohort study of consecutive cases reported to the American College of Surgeons National Surgical Quality Improvement Program (NSQIP) database between January 1, 2015, and December 31, 2019. The study population included patients in the NSQIP database who underwent operative fixation of a phalanx fracture or dislocation in 2 cohorts, those with local/regional anesthesia or general anesthesia. The predictor variables were preoperative patient demographic data, including age, gender, surgical specialty, elective surgery, diabetes, smoking, hypertension, and open wound. Results: A total of 2831 patients were identified in the NSQIP database between January 1, 2015, and December 31, 2019. Local/regional anesthesia was performed in 13% of patients with the remaining 87% receiving general anesthesia. Surgical site occurrences were not clinically significant between the 2 groups. Overall, 30-day post-operative complications in the local/regional cohort included one patient with a deep vein thrombosis (0.03%) and pulmonary embolus (0.02%). Overall, 30-day post-operative complications in the general anesthesia cohort included pneumonia (0.12%) and stroke (0.08%). Conclusions: Surgery using the regional/local anesthesia techniques for patients with phalanx fractures or dislocations is safe and can be used in situations where general anesthesia is undesirable as post-operative 30-day complications are similar to those with general anesthesia.

背景:传统上,手术修复指骨骨折是在全身麻醉下进行的。然而,区域和局部麻醉的出现,也被称为无止血带的全清醒局部麻醉,提供了一种不需要全身麻醉的替代方法。麻醉入路的选择取决于临床医生,但重要的是要考虑到区域/局部麻醉不仅提供了一种可选择的麻醉入路,而且还可能避免与全身麻醉相关的合并症。本研究假设使用局部/区域麻醉治疗指骨骨折/脱位的结果与全身麻醉相当,并且提供更少的不良事件。方法:为了回答研究目的,研究人员设计并实施了一项回顾性队列研究,该研究纳入了2015年1月1日至2019年12月31日期间向美国外科医师学会国家手术质量改进计划(NSQIP)数据库报告的连续病例。研究人群包括NSQIP数据库中接受手术固定指骨骨折或脱位的患者,分为2组,分别采用局/区域麻醉或全身麻醉。预测变量为术前患者人口统计数据,包括年龄、性别、手术专科、择期手术、糖尿病、吸烟、高血压和开放性伤口。结果:2015年1月1日至2019年12月31日,在NSQIP数据库中共发现2831例患者。13%的患者接受局/区域麻醉,其余87%的患者接受全身麻醉。两组手术部位发生率无临床差异。总体而言,局部/区域队列中30天术后并发症包括1例深静脉血栓形成(0.03%)和肺栓塞(0.02%)。总的来说,全麻组30天术后并发症包括肺炎(0.12%)和中风(0.08%)。结论:区域/局部麻醉技术对指骨骨折或脱位患者的手术是安全的,可以用于不需要全身麻醉的情况,因为术后30天的并发症与全身麻醉相似。
{"title":"Local/Regional Anesthesia Versus General Anesthesia in Phalanx Fractures/Dislocations.","authors":"Matthew D Rich, Anna Rauzi, Thomas J Sorenson, Christopher Hillard, Ashish Y Mahajan","doi":"10.1177/22925503231180886","DOIUrl":"10.1177/22925503231180886","url":null,"abstract":"<p><p><b>Background:</b> Traditionally, surgical repair of phalanx fractures was performed under general anesthesia. However, the emergence of regional and local anesthesia, otherwise known as Wide-awake Local Anesthesia No Tourniquet, provides an alternative approach where general anesthesia is undesirable. The choice of anesthetic approach resides with clinicians, though it is important to factor in the evidence that regional/local provides not only an alternative anesthesia approach but also potentially avoids comorbidities associated with general anesthesia. This study hypothesizes that the use of local/regional anesthesia for phalanx fracture/dislocation has comparable outcomes to general anesthesia and provides for fewer adverse events. <b>Methods:</b> To answer the research purpose, the investigators designed and implemented a retrospective cohort study of consecutive cases reported to the American College of Surgeons National Surgical Quality Improvement Program (NSQIP) database between January 1, 2015, and December 31, 2019. The study population included patients in the NSQIP database who underwent operative fixation of a phalanx fracture or dislocation in 2 cohorts, those with local/regional anesthesia or general anesthesia. The predictor variables were preoperative patient demographic data, including age, gender, surgical specialty, elective surgery, diabetes, smoking, hypertension, and open wound. <b>Results:</b> A total of 2831 patients were identified in the NSQIP database between January 1, 2015, and December 31, 2019. Local/regional anesthesia was performed in 13% of patients with the remaining 87% receiving general anesthesia. Surgical site occurrences were not clinically significant between the 2 groups. Overall, 30-day post-operative complications in the local/regional cohort included one patient with a deep vein thrombosis (0.03%) and pulmonary embolus (0.02%). Overall, 30-day post-operative complications in the general anesthesia cohort included pneumonia (0.12%) and stroke (0.08%). <b>Conclusions:</b> Surgery using the regional/local anesthesia techniques for patients with phalanx fractures or dislocations is safe and can be used in situations where general anesthesia is undesirable as post-operative 30-day complications are similar to those with general anesthesia.</p>","PeriodicalId":20206,"journal":{"name":"Plastic surgery","volume":null,"pages":null},"PeriodicalIF":0.7,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11528577/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"47005535","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Commentary: Breast Reconstruction Perceptions and Access in First Nations Women Are Influenced by Colonization. 受邀评论:原住民对乳房重建的看法和获得途径妇女受到殖民地化的影响
IF 0.7 4区 医学 Q4 SURGERY Pub Date : 2024-11-01 Epub Date: 2023-07-04 DOI: 10.1177/22925503231185514
Tyler Safran, Joshua Vorstenbosch
{"title":"Commentary: Breast Reconstruction Perceptions and Access in First Nations Women Are Influenced by Colonization.","authors":"Tyler Safran, Joshua Vorstenbosch","doi":"10.1177/22925503231185514","DOIUrl":"10.1177/22925503231185514","url":null,"abstract":"","PeriodicalId":20206,"journal":{"name":"Plastic surgery","volume":null,"pages":null},"PeriodicalIF":0.7,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11489941/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"44093032","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Solitary Extremity Schwannoma: A 20-Year Review of Outcomes. 孤立性肢体神经鞘瘤:20年预后回顾
IF 0.7 4区 医学 Q4 SURGERY Pub Date : 2024-11-01 Epub Date: 2023-05-03 DOI: 10.1177/22925503231169779
Rachel V Currie, Kevin M McGarry, Serena V Martin, Andrew J Robinson, Harry Lewis

Background: Reports on benign peripheral nerve sheath tumour extirpation over the last number of decades describe varying patient outcomes. We present our outcomes following excision of solitary extremity schwannoma over a 20-year period. Methods: A regional histopathology review was conducted for, "benign nerve sheath tumour" and schwannoma between 2000 and 2020. This search provided 131 histologically confirmed schwannomas that were excised from the extremities of 123 patients. Individual charts were reviewed retrospectively to establish presenting features and post-operative outcomes. Results: One hundred and twenty three patients underwent schwannoma excision, including 8 patients with synchronous tumours. The mean age at presentation was 49 years (range 11-92 years). The most common presenting symptoms were the following: palpable mass (88%), pain (70%), paraesthesia (21%), numbness (13%), and motor deficit (4%). Post-operative follow-up ranged from 1 to 168 months (mean 12.3 months) (N  =  99). Fifty-eight cases reported complete resolution of symptoms by end of outpatient follow-up (59%). The remaining reported either residual or new numbness (21%), paraesthesia (11%), pain (10%), weakness (4%), hypertrophic or keloid scar (3%), or a combination. Thirty patients (30%) developed new symptoms post-operatively including numbness (13%), paraesthesia (10%), pain (2%), and weakness (2%). There was a trend towards higher risk of post-operative pain, numbness or paraesthesia in patients undergoing excision of schwannomas on larger mixed nerves than in patients undergoing excision on smaller sensory nerves (P  =  .0531). Conclusion: Surgical excision of benign schwannomas is a successful procedure, especially for pain management, however, complete symptom resolution cannot be guaranteed, and the risk of new or persisting numbness, paraesthesia, pain, and weakness should be highlighted to patients during the consent process.

背景:在过去的几十年里,关于良性周围神经鞘肿瘤切除的报道描述了不同的患者结果。我们提出了我们的结果后切除孤立的四肢神经鞘瘤超过20年的时期。方法:对2000 ~ 2020年“良性神经鞘瘤”和神经鞘瘤的局部组织病理学进行回顾性分析。本研究提供了从123例患者的四肢切除的131例组织学证实的神经鞘瘤。回顾性回顾个别图表,以确定表现特征和术后结果。结果:123例患者行神经鞘瘤切除术,其中伴发神经鞘瘤8例。平均发病年龄为49岁(范围11-92岁)。最常见的症状如下:可触肿块(88%)、疼痛(70%)、感觉异常(21%)、麻木(13%)和运动障碍(4%)。术后随访1 ~ 168个月,平均12.3个月(N = 99)。58例患者在门诊随访结束时症状完全缓解(59%)。其余报告为残余或新的麻木(21%),感觉异常(11%),疼痛(10%),虚弱(4%),肥大或瘢痕疙瘩(3%),或两者兼而有之。30例患者(30%)术后出现新症状,包括麻木(13%)、感觉异常(10%)、疼痛(2%)和虚弱(2%)。大混合神经鞘瘤切除术患者术后出现疼痛、麻木或感觉异常的风险高于小感觉神经切除术患者(P = .0531)。结论:良性神经鞘瘤手术切除是一种成功的手术,特别是对于疼痛管理,然而,不能保证完全解决症状,并且在同意过程中应向患者强调新的或持续的麻木,感觉异常,疼痛和无力的风险。
{"title":"Solitary Extremity Schwannoma: A 20-Year Review of Outcomes.","authors":"Rachel V Currie, Kevin M McGarry, Serena V Martin, Andrew J Robinson, Harry Lewis","doi":"10.1177/22925503231169779","DOIUrl":"10.1177/22925503231169779","url":null,"abstract":"<p><p><b>Background:</b> Reports on benign peripheral nerve sheath tumour extirpation over the last number of decades describe varying patient outcomes. We present our outcomes following excision of solitary extremity schwannoma over a 20-year period. <b>Methods:</b> A regional histopathology review was conducted for, \"benign nerve sheath tumour\" and schwannoma between 2000 and 2020. This search provided 131 histologically confirmed schwannomas that were excised from the extremities of 123 patients. Individual charts were reviewed retrospectively to establish presenting features and post-operative outcomes. <b>Results:</b> One hundred and twenty three patients underwent schwannoma excision, including 8 patients with synchronous tumours. The mean age at presentation was 49 years (range 11-92 years). The most common presenting symptoms were the following: palpable mass (88%), pain (70%), paraesthesia (21%), numbness (13%), and motor deficit (4%). Post-operative follow-up ranged from 1 to 168 months (mean 12.3 months) (N  =  99). Fifty-eight cases reported complete resolution of symptoms by end of outpatient follow-up (59%). The remaining reported either residual or new numbness (21%), paraesthesia (11%), pain (10%), weakness (4%), hypertrophic or keloid scar (3%), or a combination. Thirty patients (30%) developed <i>new</i> symptoms post-operatively including numbness (13%), paraesthesia (10%), pain (2%), and weakness (2%). There was a trend towards higher risk of post-operative pain, numbness or paraesthesia in patients undergoing excision of schwannomas on larger mixed nerves than in patients undergoing excision on smaller sensory nerves (<i>P</i>  =  .0531). <b>Conclusion:</b> Surgical excision of benign schwannomas is a successful procedure, especially for pain management, however, complete symptom resolution cannot be guaranteed, and the risk of new or persisting numbness, paraesthesia, pain, and weakness should be highlighted to patients during the consent process.</p>","PeriodicalId":20206,"journal":{"name":"Plastic surgery","volume":null,"pages":null},"PeriodicalIF":0.7,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11489980/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"47649866","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Ethical Considerations Regarding Financial Incentives in Plastic Surgery-Related Health Research. 关于整形外科相关健康研究中财政激励的伦理思考
IF 0.7 4区 医学 Q4 SURGERY Pub Date : 2024-11-01 Epub Date: 2023-01-18 DOI: 10.1177/22925503221151185
Lucas Gallo, Matteo Gallo, Morgan Yuan, Sophocles H Voineskos, Ronen Avram, Mark H McRae, Matthew C McRae, Christopher J Coroneos, Lisa Schwartz, Achilles Thoma

Introduction: To recruit enough patients to achieve adequate statistical power in clinical research, investigators often rely on financial incentives. The use of these incentives, however, remains controversial as they may cause patients to overlook risks associated with research participation. This concern is amplified in the context of plastic surgery where aesthetic procedures are often more desirable and are not typically covered by public or private insurance plans. Despite this, the ethical debate regarding the use of incentives has largely been absent from plastic surgery journals; therefore, efforts to summarize the existing literature in the context of plastic surgery are necessary. Methods: A narrative review of the peer-reviewed published literature was performed to identify existing articles pertaining to financial incentives in plastic surgery-related health research. Results: While incentives have the potential to improve sample sizes and promote the recruitment of under-represented patient populations, undue inducement and biased recruitment are possible. At present, there exists a paucity of empirical evidence to substantiate this. Efforts should be taken by investigators and research ethics boards (REBs) to limit the potential negative impacts of monetary compensation. Investigators should place reasonable limits on the value of incentives as well as select models associated with lower risks of undue influence and enrollment bias. When financial remuneration is offered, additional care should be taken by investigators to ensure participants are adequately informed of the risks associated with research participation. Conclusion: Current best practice recommendations suggest that proposals submitted to REBs justify the incentives used. Information regarding incentives should also be included within study consent forms and communicated as part of the informed consent process.

为了招募足够的患者以在临床研究中获得足够的统计能力,研究人员通常依靠经济激励。然而,这些激励措施的使用仍然存在争议,因为它们可能会导致患者忽视与参与研究相关的风险。在整形手术的背景下,这种担忧被放大了,因为整形手术通常更可取,而且通常不在公共或私人保险计划的范围内。尽管如此,关于使用激励措施的伦理辩论在很大程度上没有出现在整形外科杂志上;因此,有必要在整形外科的背景下对现有文献进行总结。虽然激励措施有可能提高样本量并促进代表性不足的患者群体的招募,但不适当的诱导和有偏见的招募也是可能的。目前,缺乏实证证据来证实这一点。尽管如此,调查人员和研究伦理委员会(REB)仍应努力限制金钱补偿的潜在负面影响。研究人员应合理限制激励措施的价值,并选择与降低不当影响和招生偏见风险相关的模型。当提供经济报酬时,研究人员应格外小心,确保参与者充分了解与参与研究相关的风险。目前的最佳实践建议表明,提交给REB的提案证明了所使用的激励措施是合理的。有关激励措施的信息也应包含在研究同意书中,并作为知情同意程序的一部分传达给参与者。
{"title":"Ethical Considerations Regarding Financial Incentives in Plastic Surgery-Related Health Research.","authors":"Lucas Gallo, Matteo Gallo, Morgan Yuan, Sophocles H Voineskos, Ronen Avram, Mark H McRae, Matthew C McRae, Christopher J Coroneos, Lisa Schwartz, Achilles Thoma","doi":"10.1177/22925503221151185","DOIUrl":"10.1177/22925503221151185","url":null,"abstract":"<p><p><b>Introduction:</b> To recruit enough patients to achieve adequate statistical power in clinical research, investigators often rely on financial incentives. The use of these incentives, however, remains controversial as they may cause patients to overlook risks associated with research participation. This concern is amplified in the context of plastic surgery where aesthetic procedures are often more desirable and are not typically covered by public or private insurance plans. Despite this, the ethical debate regarding the use of incentives has largely been absent from plastic surgery journals; therefore, efforts to summarize the existing literature in the context of plastic surgery are necessary. <b>Methods:</b> A narrative review of the peer-reviewed published literature was performed to identify existing articles pertaining to financial incentives in plastic surgery-related health research. <b>Results:</b> While incentives have the potential to improve sample sizes and promote the recruitment of under-represented patient populations, undue inducement and biased recruitment are possible. At present, there exists a paucity of empirical evidence to substantiate this. Efforts should be taken by investigators and research ethics boards (REBs) to limit the potential negative impacts of monetary compensation. Investigators should place reasonable limits on the value of incentives as well as select models associated with lower risks of undue influence and enrollment bias. When financial remuneration is offered, additional care should be taken by investigators to ensure participants are adequately informed of the risks associated with research participation. <b>Conclusion:</b> Current best practice recommendations suggest that proposals submitted to REBs justify the incentives used. Information regarding incentives should also be included within study consent forms and communicated as part of the informed consent process.</p>","PeriodicalId":20206,"journal":{"name":"Plastic surgery","volume":null,"pages":null},"PeriodicalIF":0.7,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11490959/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"48988155","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Patient Factors Associated with Increased Cancer Worry, Fatigue, and Impact on Work Following a Breast Cancer Diagnosis: A Cross-Sectional Analysis. 乳腺癌诊断后与癌症担忧增加、疲劳和工作影响相关的患者因素:一项横断面分析
IF 0.7 4区 医学 Q4 SURGERY Pub Date : 2024-11-01 Epub Date: 2023-03-17 DOI: 10.1177/22925503231161067
Sophocles H Voineskos, Lucas Gallo, Manraj Kaur, Elena Tsangaris, Lauren Griffith, Jonas A Nelson, Anne F Klassen, Andrea L Pusic

Introduction: A breast cancer diagnosis may result in disabling effects which may persist after treatment. The aim of this study was to identify patient factors that are associated with increased cancer worry, fatigue, and impact on work. Methods: Women with a history of breast cancer, aged ≥18 years, and English-speaking were recruited through the Love Research Army between October and November 2019. Participants completed demographic and clinical questions alongside the BREAST-Q Cancer Worry, Fatigue, and Impact on Work scales. Univariable and multivariable regression analyses were used to identify participant characteristics associated with each scale. Results: Cancer Worry, Fatigue, and Impact on Work scales were completed by n = 1680, n = 1037, and n = 873 participants, respectively. Most participants were older than 50 (n = 1,470, 87.5%), married (n = 1229, 73.2%), white (n = 1557, 92.7%), and had undergone surgery for cancer treatment (n = 1,472, 87.6%). Increased Cancer Worry was significantly associated (P < .04) with younger age, less time since diagnosis, pain related to cancer/treatment, recurrence, prior chemotherapy, and ongoing breast edema. Increased Fatigue was significantly associated (P < .01) with elevated BMI, less time since diagnosis, ethnicity, employment status, recurrence, prior chemotherapy, ongoing pain, and difficulty sleeping secondary to treatment. Decreased Impact on Work scores was significantly associated (P < .04) with chemotherapy administration, shorter time since diagnosis, employment, fatigue related to treatment, breast edema, and ongoing pain. Conclusion: This study reveals patient characteristics associated with increased cancer worry, fatigue, and a negative impact on work following a breast cancer diagnosis. These findings can inform clinical and research initiatives to better support patients through treatment and survivorship.

简介:癌症诊断可能会导致致残效应,这种效应可能在治疗后持续存在。本研究的目的是确定与癌症担忧、疲劳和工作影响增加相关的患者因素。方法:在2019年10月至11月期间,通过爱研究军招募有癌症病史、年龄≥18岁、有英国血统的女性。参与者完成了人口统计学和临床问题,以及BREST-Q癌症担忧、疲劳和对工作的影响量表。使用单变量和多变量回归分析来确定与每个量表相关的参与者特征。结果:癌症焦虑、疲劳和对工作的影响量表由n完成 = 1680,n = 1037和n = 873名参与者。大多数参与者年龄在50岁以上(n = 1470,87.5%),已婚(n = 1229,73.2%),白色(n = 1557例,92.7%),并接受过癌症手术治疗(n = 与癌症担忧增加有显著相关性(P < .04)年龄较小,诊断后时间较短,与癌症/治疗相关的疼痛,复发,既往化疗和持续性乳房水肿。疲劳程度的增加显著相关(P < .01)BMI升高,确诊后时间缩短,种族,就业状况,复发,既往化疗,持续疼痛,治疗后睡眠困难。工作影响降低与工作成绩显著相关(P < .04)化疗给药、诊断后时间更短、工作、与治疗相关的疲劳、乳房水肿和持续疼痛。结论:本研究揭示了在癌症诊断后,与癌症担忧、疲劳和对工作的负面影响增加相关的患者特征。这些发现可以为临床和研究计划提供信息,以更好地支持患者的治疗和生存。
{"title":"Patient Factors Associated with Increased Cancer Worry, Fatigue, and Impact on Work Following a Breast Cancer Diagnosis: A Cross-Sectional Analysis.","authors":"Sophocles H Voineskos, Lucas Gallo, Manraj Kaur, Elena Tsangaris, Lauren Griffith, Jonas A Nelson, Anne F Klassen, Andrea L Pusic","doi":"10.1177/22925503231161067","DOIUrl":"10.1177/22925503231161067","url":null,"abstract":"<p><p><b>Introduction:</b> A breast cancer diagnosis may result in disabling effects which may persist after treatment. The aim of this study was to identify patient factors that are associated with increased cancer worry, fatigue, and impact on work. <b>Methods:</b> Women with a history of breast cancer, aged ≥18 years, and English-speaking were recruited through the Love Research Army between October and November 2019. Participants completed demographic and clinical questions alongside the BREAST-Q Cancer Worry, Fatigue, and Impact on Work scales. Univariable and multivariable regression analyses were used to identify participant characteristics associated with each scale. <b>Results:</b> Cancer Worry, Fatigue, and Impact on Work scales were completed by <i>n</i> = 1680, <i>n</i> = 1037, and <i>n</i> = 873 participants, respectively. Most participants were older than 50 (<i>n</i> = 1,470, 87.5%), married (<i>n</i> = 1229, 73.2%), white (<i>n</i> = 1557, 92.7%), and had undergone surgery for cancer treatment (<i>n</i> = 1,472, 87.6%). Increased Cancer Worry was significantly associated (<i>P</i> < .04) with younger age, less time since diagnosis, pain related to cancer/treatment, recurrence, prior chemotherapy, and ongoing breast edema. Increased Fatigue was significantly associated (<i>P</i> < .01) with elevated BMI, less time since diagnosis, ethnicity, employment status, recurrence, prior chemotherapy, ongoing pain, and difficulty sleeping secondary to treatment. Decreased Impact on Work scores was significantly associated (<i>P</i> < .04) with chemotherapy administration, shorter time since diagnosis, employment, fatigue related to treatment, breast edema, and ongoing pain. <b>Conclusion:</b> This study reveals patient characteristics associated with increased cancer worry, fatigue, and a negative impact on work following a breast cancer diagnosis. These findings can inform clinical and research initiatives to better support patients through treatment and survivorship.</p>","PeriodicalId":20206,"journal":{"name":"Plastic surgery","volume":null,"pages":null},"PeriodicalIF":0.7,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11490967/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"44766387","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Recurrent Allergic Contact Dermatitis to Bacitracin Used in Pocket Irrigation During Breast Reconstruction Surgery. 乳房重建术中应用杆菌肽袋冲洗的复发性过敏性接触性皮炎
IF 0.7 4区 医学 Q4 SURGERY Pub Date : 2024-11-01 Epub Date: 2023-04-17 DOI: 10.1177/22925503231169776
Chaocheng Liu, Gillian de Gannes

Allergic contact dermatitis (ACD) is a delayed-type hypersensitivity reaction that presents as a pruritic eczematous rash occurring 24 to 48 h after allergen exposure. It is a surgical complication that can impact people's quality of life after plastic surgeries. A 44-year-old female with right breast cancer presented with three recurrent episodes of severe pruritic cutaneous eczematous eruption over her right breast extending down to her trunk and vulva each time soon after her multiple breast surgeries. She was labeled as having allergies to several intravenous antibiotics received perioperatively. She was then patch tested with a positive reaction to bacitracin, a component of a modified double antibiotic solution used for pocket irrigation intraoperatively. It highlights the need for plastic surgeons to consider ACD to bacitracin in patients with dermatitis soon after having bacitracin for pocket irrigation or implant soaking during breast surgeries. Comprehensive patch testing can delineate the cause of surgery-related ACD.

过敏性接触性皮炎(ACD)是一种延迟型超敏反应,表现为接触过敏原后24至48小时出现瘙痒性湿疹皮疹。这是一种手术并发症,可以影响人们在整形手术后的生活质量。一位44岁女性右乳房癌患者在多次乳房手术后,出现三次反复发作的严重瘙痒性皮肤湿疹,其右乳房延伸至躯干和外阴。她被标记为对围手术期静脉注射的几种抗生素过敏。然后对她进行贴片试验,发现对杆菌肽有阳性反应,杆菌肽是一种改良的双抗生素溶液的成分,用于术中口袋冲洗。它强调了整形外科医生在乳房手术中对杆菌肽进行口袋冲洗或植入物浸泡后不久的皮炎患者考虑ACD的必要性。全面的贴片测试可以描述手术相关ACD的原因。
{"title":"Recurrent Allergic Contact Dermatitis to Bacitracin Used in Pocket Irrigation During Breast Reconstruction Surgery.","authors":"Chaocheng Liu, Gillian de Gannes","doi":"10.1177/22925503231169776","DOIUrl":"10.1177/22925503231169776","url":null,"abstract":"<p><p>Allergic contact dermatitis (ACD) is a delayed-type hypersensitivity reaction that presents as a pruritic eczematous rash occurring 24 to 48 h after allergen exposure. It is a surgical complication that can impact people's quality of life after plastic surgeries. A 44-year-old female with right breast cancer presented with three recurrent episodes of severe pruritic cutaneous eczematous eruption over her right breast extending down to her trunk and vulva each time soon after her multiple breast surgeries. She was labeled as having allergies to several intravenous antibiotics received perioperatively. She was then patch tested with a positive reaction to bacitracin, a component of a modified double antibiotic solution used for pocket irrigation intraoperatively. It highlights the need for plastic surgeons to consider ACD to bacitracin in patients with dermatitis soon after having bacitracin for pocket irrigation or implant soaking during breast surgeries. Comprehensive patch testing can delineate the cause of surgery-related ACD.</p>","PeriodicalId":20206,"journal":{"name":"Plastic surgery","volume":null,"pages":null},"PeriodicalIF":0.7,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11489897/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"45139029","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A Novel Approach to the Treatment of Comminuted Mandibular Condyle Fractures. 一种治疗粉碎性髁突骨折的新方法
IF 0.7 4区 医学 Q4 SURGERY Pub Date : 2024-11-01 Epub Date: 2023-06-04 DOI: 10.1177/22925503231175505
Paige Knight, Lindsay Bjornson, Rebecca Courtemanche, Douglas J Courtemanche

Introduction: A suture enlocation (SE) approach is proposed to manage comminuted intra-articular mandibular condyle fractures not amenable to open reduction internal fixation approaches. The SE approach is an effective operative option for the treatment of condylar fractures with the combination of fracture dislocation, malocclusion, comminution, and inadequate surface area for open fixation techniques. This study describes the SE approach, outcomes, and complications. Methods: The SE technique is described, and the health records of patients treated with the SE approach are reviewed. Outcome data were collected for diet, interincisal opening, occlusion, pain, and complications. Results: Technique: The SE approach involves reducing the fractured condylar fragment using a hole drilled through the fragment to secure it to the periosteum with a polydioxanone suture. This allows the reduced fragment to be managed as a nondisplaced fracture with mandibulomaxillary fixation and class 2 elastics. Outcomes: A chart review involving 8 patients (11 condyles) illustrates the outcomes of the SE approach from 2006 to 2021. Age at the time of injury ranged from 12 to 51 years and the follow up ranged from 2 to 68 months. At final follow up, 7 patients were eating a regular diet, 7 had normal interincisal opening, 4 had normal occlusion, and 4 reported ongoing mandibular discomfort. Failure of fixation occurred in 1 case, which required further operative management. Conclusions: The SE technique shows promise as an effective way to reduce fracture components, manage occlusion, and facilitate secondary bone healing in comminuted and displaced mandibular condyle fractures.

介绍:我们提出了一种缝合内固定(SE)入路来治疗不能采用切开复位内固定入路的粉碎性下颌髁内骨折。SE入路是治疗髁突骨折合并骨折脱位、错牙合、粉碎性骨折和开放固定技术面积不足的有效手术选择。本研究描述了SE入路、结果和并发症。方法:介绍了超声造影技术,并回顾了经超声造影治疗的患者的健康记录。收集饮食、切开、咬合、疼痛和并发症的结局数据。结果:技术:SE入路包括使用钻穿碎片的孔将其固定在骨膜上,并使用聚二氧环酮缝线将骨折的髁碎片复位。这使得复位碎片可以作为非移位性骨折进行治疗,采用下颌颌骨固定和2级弹性固定。结果:一项涉及8例患者(11个髁)的图表回顾说明了2006年至2021年SE入路的结果。损伤时年龄12 ~ 51岁,随访2 ~ 68个月。最后随访时,7例患者饮食正常,7例牙周开口正常,4例牙合正常,4例持续下颌不适。1例固定失败,需进一步手术处理。结论:在粉碎性和移位的下颌髁骨折中,SE技术有望成为减少骨折成分、处理咬合和促进继发性骨愈合的有效方法。
{"title":"A Novel Approach to the Treatment of Comminuted Mandibular Condyle Fractures.","authors":"Paige Knight, Lindsay Bjornson, Rebecca Courtemanche, Douglas J Courtemanche","doi":"10.1177/22925503231175505","DOIUrl":"10.1177/22925503231175505","url":null,"abstract":"<p><p><b>Introduction:</b> A suture enlocation (SE) approach is proposed to manage comminuted intra-articular mandibular condyle fractures not amenable to open reduction internal fixation approaches. The SE approach is an effective operative option for the treatment of condylar fractures with the combination of fracture dislocation, malocclusion, comminution, and inadequate surface area for open fixation techniques. This study describes the SE approach, outcomes, and complications. <b>Methods:</b> The SE technique is described, and the health records of patients treated with the SE approach are reviewed. Outcome data were collected for diet, interincisal opening, occlusion, pain, and complications. <b>Results:</b> <i>Technique:</i> The SE approach involves reducing the fractured condylar fragment using a hole drilled through the fragment to secure it to the periosteum with a polydioxanone suture. This allows the reduced fragment to be managed as a nondisplaced fracture with mandibulomaxillary fixation and class 2 elastics. <i>Outcomes:</i> A chart review involving 8 patients (11 condyles) illustrates the outcomes of the SE approach from 2006 to 2021. Age at the time of injury ranged from 12 to 51 years and the follow up ranged from 2 to 68 months. At final follow up, 7 patients were eating a regular diet, 7 had normal interincisal opening, 4 had normal occlusion, and 4 reported ongoing mandibular discomfort. Failure of fixation occurred in 1 case, which required further operative management. <b>Conclusions:</b> The SE technique shows promise as an effective way to reduce fracture components, manage occlusion, and facilitate secondary bone healing in comminuted and displaced mandibular condyle fractures.</p>","PeriodicalId":20206,"journal":{"name":"Plastic surgery","volume":null,"pages":null},"PeriodicalIF":0.7,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11528576/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"43158552","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Plastic surgery
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1